0000899243-18-006557.txt : 20180306 0000899243-18-006557.hdr.sgml : 20180306 20180306203208 ACCESSION NUMBER: 0000899243-18-006557 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180302 FILED AS OF DATE: 20180306 DATE AS OF CHANGE: 20180306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Paul CENTRAL INDEX KEY: 0001657568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 333-199861 FILM NUMBER: 18671678 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE STREET 2: MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mylan N.V. CENTRAL INDEX KEY: 0001623613 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981189497 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL BUSINESS PHONE: 44 0 1707 853 000 MAIL ADDRESS: STREET 1: BUILDING 4, TRIDENT PLACE, MOSQUITO WAY CITY: HATFIELD, HERTFORDSHIRE STATE: X0 ZIP: AL10 9UL FORMER COMPANY: FORMER CONFORMED NAME: New Moon B.V. DATE OF NAME CHANGE: 20141028 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-02 0 0001623613 Mylan N.V. MYL 0001657568 Campbell Paul BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL UNITED KINGDOM 0 1 0 0 See Remarks Ordinary Shares 2018-03-03 4 M 0 831 0.00 A 17054 D Ordinary Shares 2018-03-03 4 F 0 357 40.97 D 16697 D Ordinary Shares 2018-03-03 4 M 0 220 0.00 A 220 I By Spouse Ordinary Shares 2018-03-03 4 F 0 75 40.97 D 145 I By Spouse Ordinary Shares 2018-03-04 4 X 0 480 0.00 A 17177 D Ordinary Shares 2018-03-04 4 F 0 206 40.97 D 16971 D Ordinary Shares 2018-03-04 4 X 0 190 0.00 A 335 I By Spouse Ordinary Shares 2018-03-04 4 F 0 65 40.97 D 270 I By Spouse Ordinary Shares 2018-03-04 4 M 0 1081 0.00 A 18052 D Ordinary Shares 2018-03-04 4 F 0 530 40.97 D 17522 D Ordinary Shares 2018-03-06 4 X 0 7030 11.18 A 24552 D Ordinary Shares 2018-03-06 4 S 0 7030 44.01 D 17522 D Ordinary Shares 2018-03-06 4 X 0 5766 12.15 A 23288 D Ordinary Shares 2018-03-06 4 F 0 1621 43.23 D 21667 D Ordinary Shares 318 I By 401(k) Plan Employee Stock Option - Right to Buy 40.97 2018-03-02 4 A 0 9681 0.00 A 2028-03-02 Ordinary Shares 9681 9681 D Employee Stock Option - Right to Buy 40.97 2018-03-02 4 A 0 612 0.00 A 2028-03-02 Ordinary Shares 612 612 I By Spouse Restricted Stock Units 0.00 2018-03-02 4 A 0 5940 0.00 A Ordinary Shares 5940 5940 D Restricted Stock Units 0.00 2018-03-02 4 A 0 501 0.00 A Ordinary Shares 501 501 I By Spouse Restricted Stock Units 0.00 2018-03-03 4 M 0 831 0.00 D Ordinary Shares 831 1660 D Restricted Stock Units 0.00 2018-03-03 4 M 0 220 0.00 D Ordinary Shares 220 439 I By Spouse Restricted Stock Units 0.00 2018-03-04 4 X 0 480 0.00 D Ordinary Shares 480 0 D Restricted Stock Units 0.00 2018-03-04 4 X 0 190 0.00 D Ordinary Shares 190 0 I By Spouse Performance Restricted Stock Units 0.00 2018-03-04 4 M 0 1081 0.00 D Ordinary Shares 1081 0 D Employee Stock Option - Right to Buy 11.18 2018-03-06 4 X 0 7030 0.00 D 2018-03-18 Ordinary Shares 7030 0 D Employee Stock Option - Right to Buy 12.15 2018-03-06 4 X 0 5766 0.00 D 2009-03-05 Ordinary Shares 5766 11533 D Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the restricted stock units (RSUs) granted on March 3, 2017. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of a portion of the RSUs granted on March 4, 2015. Represents withholding of ordinary shares for the tax liability associated with the vesting and settlement of the performance restricted stock units (PRSUs) granted on March 4, 2015. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 18, 2008. Represents the acquisition of Mylan ordinary shares upon exercise of stock options granted on March 5, 2009. Represents the delivery of ordinary shares to satisfy the exercise price associated with the exercise of stock options granted on March 5, 2009. These options vest in three equal annual installments beginning on March 2, 2019 and expire on March 2, 2028. Each RSU represents the right to receive one ordinary share of Mylan N.V. The RSUs vest in three equal annual installments beginning on March 2, 2019. Each RSU represents the right to receive one ordinary share of Mylan N.V. 831 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 830 will vest on March 3, 2019, and 830 will vest on March 3, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 220 of the RSUs granted on March 3, 2017 vested on March 3, 2018, 219 will vest on March 3, 2019, and 220 will vest on March 3, 2020. Each RSU represents the right to receive one ordinary share of Mylan N.V. 481 of the RSUs granted on March 4, 2015 vested on March 4, 2016, and 480 vested on each of March 4, 2017 and March 4, 2018. Each RSU represents the right to receive one ordinary share of Mylan N.V. 190 of the RSUs granted on March 4, 2015 vested on March 4, 2016, 189 vested on March 4, 2017, and 190 vested on March 4, 2018. Each PRSU represents the right to receive one ordinary share of Mylan N.V. The PRSUs were initially granted on March 4, 2015, subject to the attainment of previously established three-year performance goals and a vesting period. The PRSUs fully vested on March 4, 2018. The grant, of which these options were a part, vested in three equal installments beginning on March 18, 2009. The grant, of which these options were a part, vested in three equal installments beginning on March 5, 2010. Senior Vice President, Chief Accounting Officer & Corporate Controller /s/ Kevin Macikowski, by power of attorney 2018-03-06